← Back to Clinical Trials
Recruiting NCT06285357
The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.
Trial Parameters
Condition HPV Infection
Sponsor Lo.Li.Pharma s.r.l
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex FEMALE
Min Age 25 Years
Max Age 65 Years
Start Date 2024-02-19
Completion 2026-03
Interventions
EGCG + folic acid + B12
Brief Summary
The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.
Eligibility Criteria
Inclusion Criteria: * HR-HPV DNA test positivity Exclusion Criteria: * No HSIL